Girard, N., Corral, J., Cortinovis, D., Heigener, D. (2016). 183P: Second-line treatment selection in patients with non-small cell lung cancer of adenocarcinoma histology: A European survey. In Abstracts of European Lung Cancer Conference (ELCC) 13 April 2016 - 16 April 2016 (pp.137-137). Elsevier Inc [10.1016/S1556-0864(16)30293-3].

183P: Second-line treatment selection in patients with non-small cell lung cancer of adenocarcinoma histology: A European survey

Cortinovis D.;
2016

abstract
Article; cancer growth; cancer patient; cancer staging; cancer survival; cancer therapy; clinical assessment tool; cost benefit analysis; disease activity; disease marker; Eastern Cooperative Oncology Group performance status; Germany; health care need; histopathology; human; Italy; lung adenocarcinoma; medical decision making; non small cell lung cancer; oncologist; overall survival; physician; physician attitude; prescription; priority journal; pulmonologist; quality of life; Spain; treatment planning; United Kingdom
English
European Lung Cancer Conference (ELCC) 13 April 2016 - 16 April 2016
2016
Abstracts of European Lung Cancer Conference (ELCC) 13 April 2016 - 16 April 2016
2016
11
S4
137
137
none
Girard, N., Corral, J., Cortinovis, D., Heigener, D. (2016). 183P: Second-line treatment selection in patients with non-small cell lung cancer of adenocarcinoma histology: A European survey. In Abstracts of European Lung Cancer Conference (ELCC) 13 April 2016 - 16 April 2016 (pp.137-137). Elsevier Inc [10.1016/S1556-0864(16)30293-3].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/576114
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact